AMRN three-lens brief
Evidence-based stock research on AMRN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.43% yesterday. · Trading at 14% of its 52-week range — deep in the lower band.
- Moved -2.43% yesterday.
- Trading at 14% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Negative free cash flow last quarterly (-$5.57M).
AMRN closed at $14.04 (-2.43%) as of 2026-09-11. Market cap: $294.41M. Price is below the 50-day MA and below the 200-day MA. Concerns: moved -2.43% yesterday.; trading at 14% of its 52-week range — deep in the lower band.. Last quarter: Revenue $42.21M, free cash flow -$5.57M.
Why three lenses on AMRN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMRNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMRN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMRN brief"></iframe>